Evolution of randomized controlled trials and surrogacy of progression-free survival in advanced/metastatic urothelial cancer

PFS is strongly correlated with OS in trials of advanced/metastatic urothelial cancer assessing the treatment benefit of new drugs And PFS warrants further exploration as a surrogate endpoint in clinical trial datasets.